Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel S Merseburger

Showing results (141-150 of 323) with videos related to

Pageof 33
Sort By:
Urologia Internationalis|February 17, 2021
Risk Factors for a Complicated Postoperative Course in Flexible UreteroscopyTomasz Ozimek, Laura Hochguertel, Marie C Hupe, et al.
World Journal of Urology|June 18, 2014
Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014Mario W Kramer, Mathias Wolters, Hannes Cash, et al.
European Urology|April 6, 2007
Renal cell carcinoma guidelineBörje Ljungberg, Damian C Hanbury, Marcus A Kuczyk, et al.
World Journal of Urology|October 30, 2019
Laser fibre, rather than the stone, may harm the scope: retrospective monocentric analysis of 26 pre- and intraoperative factors of flexible ureteroscope (fURS) damageTomasz Ozimek, Jens Cordes, Nils Gilbert, et al.
Journal of Endourology|May 9, 2018
Steep Infundibulopelvic Angle as a New Risk Factor for Flexible Ureteroscope Damage and Complicated Postoperative CourseTomasz Ozimek, Jens Cordes, Judith R Wiessmeyer, et al.
Springerplus|July 16, 2013
Incidence of synchronous and metachronous adrenal metastases following tumor nephrectomy in renal cell cancer patients: a retrospective bi-center analysisInga Peters, Milan Hora, Thomas R Herrmann, et al.
BMC Urology|June 15, 2022
The dilemma of 12/14F ureteral access sheath (UAS) usage: a case control studyTomasz Ozimek, Judith R Wiessmeyer, Julian P Struck, et al.
World Journal of Urology|May 6, 2011
Current evidence for transurethral laser therapy of non-muscle invasive bladder cancerMario W Kramer, Thorsten Bach, Mathias Wolters, et al.
World Journal of Urology|May 26, 2007
The rationale for radical cystectomy as primary therapy for T4 bladder cancerUdo Nagele, Aristotelis G Anastasiadis, Axel S Merseburger, et al.
Korean Journal of Urology|January 20, 2015
Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical studyRania Makboul, Abeer E L-Refaiy M Refaiy, Fatma Ahmed Mahmoud Badary, et al.
Pageof 33

Showing results (141-150 of 323) with videos related to

Sort By:
Pageof 33
Urologia Internationalis|February 17, 2021
Risk Factors for a Complicated Postoperative Course in Flexible UreteroscopyTomasz Ozimek, Laura Hochguertel, Marie C Hupe, et al.
World Journal of Urology|June 18, 2014
Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014Mario W Kramer, Mathias Wolters, Hannes Cash, et al.
European Urology|April 6, 2007
Renal cell carcinoma guidelineBörje Ljungberg, Damian C Hanbury, Marcus A Kuczyk, et al.
World Journal of Urology|October 30, 2019
Laser fibre, rather than the stone, may harm the scope: retrospective monocentric analysis of 26 pre- and intraoperative factors of flexible ureteroscope (fURS) damageTomasz Ozimek, Jens Cordes, Nils Gilbert, et al.
Journal of Endourology|May 9, 2018
Steep Infundibulopelvic Angle as a New Risk Factor for Flexible Ureteroscope Damage and Complicated Postoperative CourseTomasz Ozimek, Jens Cordes, Judith R Wiessmeyer, et al.
Springerplus|July 16, 2013
Incidence of synchronous and metachronous adrenal metastases following tumor nephrectomy in renal cell cancer patients: a retrospective bi-center analysisInga Peters, Milan Hora, Thomas R Herrmann, et al.
BMC Urology|June 15, 2022
The dilemma of 12/14F ureteral access sheath (UAS) usage: a case control studyTomasz Ozimek, Judith R Wiessmeyer, Julian P Struck, et al.
World Journal of Urology|May 6, 2011
Current evidence for transurethral laser therapy of non-muscle invasive bladder cancerMario W Kramer, Thorsten Bach, Mathias Wolters, et al.
World Journal of Urology|May 26, 2007
The rationale for radical cystectomy as primary therapy for T4 bladder cancerUdo Nagele, Aristotelis G Anastasiadis, Axel S Merseburger, et al.
Korean Journal of Urology|January 20, 2015
Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical studyRania Makboul, Abeer E L-Refaiy M Refaiy, Fatma Ahmed Mahmoud Badary, et al.
Pageof 33